Chidamide in Combination With Abemaciclib and Endocrinotherapy（Doctor's Choice） in Breast Cancer Patients Previously Treated With Palbociclib (CINDERELLA)

NCT05464173 PHASE1, PHASE2 UNKNOWN

To evaluate the efficacy and safety of chidamide in combination with abemaciclib and endocrinotherapy（doctor's choice） in locally advanced/metastatic HR+/HER2- breast cancer who had failed prior palbociclib therapy

Details

Lead sponsor	Biyun Wang, MD
Phase	PHASE1, PHASE2
Status	UNKNOWN
Enrolment	44
Start date	Fri Jul 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu May 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Breast Cancer

Interventions

• Chidamide
• Abemaciclib
• endocrinotherapy（doctor's choice）

Countries

China